Atorvastatin vs. Rosuvastatin
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
What's the purpose of the trial?
This is a pilot study to explore the role of statins in treatment of patients with CCUS and lower-risk MDS.
Accepting patients
For Healthcare Professionals Only
This site is intended for healthcare professionals in the US. Patients and care partners can explore and connect with MDS clinical trials through our patient portal.
Participating Centers
There is one center participating in this trial. Enter a location below to view the distance.
Experimental Treatments
Learn more about the experimental treatments being evaluated in this clinical trial.
- Atorvastatin is an HMG-CoA reductase inhibitor that is approved to treat high cholesterol and is being studied for use in treating cancer.
- Rosuvastatin Calcium is an HMG-CoA reductase inhibitor that is approved for the treatment of high cholesterol.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.